{
    "clinical_study": {
        "@rank": "55419", 
        "arm_group": [
            {
                "arm_group_label": "Generic clopidogrel product", 
                "arm_group_type": "Experimental", 
                "description": "Apolets\u00ae 75 mg tablet"
            }, 
            {
                "arm_group_label": "Original clopidogrel product", 
                "arm_group_type": "Active Comparator", 
                "description": "Plavix\u00ae 75mg tablet"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the pharmacodynamic effect of clopidogrel on the\n      platelet inhibition and the pharmacokinetic profiles of clopidogrel carboxylic acid\n      metabolite between generic and reference clopidogrel products in Thai healthy volunteers"
        }, 
        "brief_title": "Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Antiplatelet Agents", 
        "detailed_description": {
            "textblock": "Platelet aggregation (ex vivo) were measured by using  Whole blood impedence aggregometry\n      (Chrono-log\u00ae) and VerifyNow\u00ae P2Y12 assay. Plasma concentration of clopidogrel carboxylic\n      acid metabolite were measured by High performance liquid chromatography (HPLC)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 18 and 45 years\n\n          -  Body mass index between 18-25 kg/m2\n\n          -  No clinically significant abnormalities, as confirmed on medical history; detailed\n             physical examination; clinical laboratory analysis (blood hematology, biochemistry,\n             prothrombin time, bleeding time, and urinalysis)\n\n        Exclusion Criteria:\n\n          -  An allergy to any drug; and/or a history of drug and/or alcohol abuse.\n\n          -  Subjects who had donated blood within 3 months prior to the start of this study or\n             had participated in another investigational drug study within 3 months prior to the\n             start of this study\n\n          -  Participating subjects were instructed to abstain from the use of any drugs for at\n             least 2 weeks before and throughout the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02010632", 
            "org_study_id": "PDPK-CLO-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Generic clopidogrel product", 
                "description": "Clopidogrel 75 mg once daily for 7 days\nBlood collection at 0 (before dosing), 1, 2, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7", 
                "intervention_name": "Generic clopidogrel product Apolets\u00ae", 
                "intervention_type": "Drug", 
                "other_name": "Apolets\u00ae"
            }, 
            {
                "arm_group_label": "Original clopidogrel product", 
                "description": "Clopidogrel  75 mg once daily for 7 days\nBlood collection at 0 (before dosing), 1, 2, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7", 
                "intervention_name": "Original clopidogrel product Plavix\u00ae", 
                "intervention_type": "Drug", 
                "other_name": "Plavix\u00ae"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clopidogrel", 
                "Ticlopidine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Clopidogrel", 
            "Platelet inhibition", 
            "Platelet aggregation"
        ], 
        "lastchanged_date": "December 12, 2013", 
        "location": {
            "contact": {
                "email": "wichitt@kku.ac.th", 
                "last_name": "Wichittra Tassaneeyakul, Ph.D.", 
                "phone": "6643348397"
            }, 
            "contact_backup": {
                "email": "nonna_na@hotmail.com", 
                "last_name": "Nontaya Nakkam, B.Pharm", 
                "phone": "66862642540"
            }, 
            "facility": {
                "address": {
                    "city": "Khonkaen", 
                    "country": "Thailand", 
                    "state": "Khon Kaen", 
                    "zip": "40000"
                }, 
                "name": "Faculty of Medicine, Khon Kaen University"
            }, 
            "investigator": {
                "last_name": "Wichittra Tassaneeyakul, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products in Thai Healthy Volunteers", 
        "overall_contact": {
            "email": "wichitt@kku.ac.th", 
            "last_name": "Wichittra Tassaneeyakul, Ph.D.", 
            "phone": "+66-43-348397"
        }, 
        "overall_contact_backup": {
            "email": "somtia@kku.ac.th", 
            "last_name": "Somsak Tiamkao, MD", 
            "phone": "+66-43-363-665"
        }, 
        "overall_official": [
            {
                "affiliation": "Khon Kaen University", 
                "last_name": "Wichittra Tassaneeyakul, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Khon Kaen University", 
                "last_name": "Somsak Tiamkao, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Khon Kaen University", 
                "last_name": "Sirimas Kanjanawart, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Khon Kaen University", 
                "last_name": "Kutcharin Phunikhom, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Khon Kaen University", 
                "last_name": "Nontaya Nakkam, B.Pharm", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Khon Kaen University", 
                "last_name": "Thanawat Kaewkamsorn, M.Sc.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Khon Kaen University Ethics Committee for Human Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pharmacodynamic effect: The platelet inhibition effect of clopidogrel at the various times on day 7 (0-24 hours) (at steady state)", 
            "safety_issue": "No", 
            "time_frame": "Blood collection at 0 (before dosing), 1, 2, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02010632"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Khon Kaen University", 
            "investigator_full_name": "Wichittra Tassaneeyakul", 
            "investigator_title": "Professor Dr. Wichittra Tassaneeyakul, Departments of Pharmacology, Faculty of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pharmacokinetic profiles: Area Under the Concentration-Time Curve (AUC 0-24)", 
                "safety_issue": "No", 
                "time_frame": "Blood collection at 0 (before dosing), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7"
            }, 
            {
                "measure": "Pharmacokinetic profiles: The Maximum Plasma Concentration (Cmax)", 
                "safety_issue": "No", 
                "time_frame": "Blood collection at 0 (before dosing), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7"
            }, 
            {
                "measure": "Pharmacokinetic profiles: Time to Maximum Plasma Concentration (Tmax)", 
                "safety_issue": "No", 
                "time_frame": "Blood collection at 0 (before dosing), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7"
            }
        ], 
        "source": "Khon Kaen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Khon Kaen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}